These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 3546388)
1. Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma. Smith ME; Holgate CS; Williamson JM; Grigor I; Quirke P; Bird CC J Clin Pathol; 1987 Jan; 40(1):34-41. PubMed ID: 3546388 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells. Howard DR; Eaves AC; Takei F Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652 [TBL] [Abstract][Full Text] [Related]
3. B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain. Momburg F; Herrmann B; Moldenhauer G; Möller P Int J Cancer; 1987 Nov; 40(5):598-603. PubMed ID: 3316049 [TBL] [Abstract][Full Text] [Related]
4. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis. Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products. Puri NK; de Kretser T; Brandon MR Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma. van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252 [TBL] [Abstract][Full Text] [Related]
7. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635 [TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies specific for HLA-A,B,C,DR,DQ and DP by the erythrocyte antibody rosette inhibition (EAI) and immune phagocytosis inhibition (IPI) tests. Faust A; Neppert J J Immunol Methods; 1987 Aug; 102(1):71-5. PubMed ID: 3476673 [TBL] [Abstract][Full Text] [Related]
9. Gamma interferon induces detectable serological and functional expression of DR and DP but not DQ antigens on cultured amniotic fluid cells. Maurer DH; Callaway C; Sorkin S; Pollack MS Tissue Antigens; 1988 Apr; 31(4):174-82. PubMed ID: 3136555 [TBL] [Abstract][Full Text] [Related]
10. Oncogene-derived peptides: a new class of tumor rejection antigens? Gedde-Dahl T; Olsen BH; Thorsby E; Gaudernack G Transplant Proc; 1993 Feb; 25(1 Pt 2):1385-6. PubMed ID: 8442151 [No Abstract] [Full Text] [Related]
11. Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for "frustrated" activation. Pitzalis C; Kingsley G; Lanchbury JS; Murphy J; Panayi GS J Rheumatol; 1987 Aug; 14(4):662-6. PubMed ID: 3118018 [TBL] [Abstract][Full Text] [Related]
12. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells. Brooks CF; Moore M Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576 [TBL] [Abstract][Full Text] [Related]
13. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation. Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326 [TBL] [Abstract][Full Text] [Related]
14. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP. Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208 [TBL] [Abstract][Full Text] [Related]
15. The role of HLA class II antigens in the induction of cytotoxic T lymphocytes. Demesová V; Buc M; Ferencík S; Sasazuki T; Shawkatová I; Porubská S Eur J Immunogenet; 1995 Dec; 22(6):425-34. PubMed ID: 8597559 [TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex (MHC) class II antigen (HLA-DR, DQ, and DP) expression in human fetal endocrine organs and gut. Oliver AM; Thomson AW; Sewell HF; Abramovich DR Scand J Immunol; 1988 Jun; 27(6):731-7. PubMed ID: 3293192 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression. Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732 [TBL] [Abstract][Full Text] [Related]
18. Differential tissue distribution of HLA-DR, -DP and -DQ antigens. Forsum U; Claesson K; Jonsson R; Karlsson-Parra A; Klareskog L; Scheynius A; Tjernlund U Adv Exp Med Biol; 1987; 216A():233-9. PubMed ID: 3687525 [No Abstract] [Full Text] [Related]
19. Expression of class II antigens by subsets of activated T cells. Zier KS Cell Immunol; 1986 Jul; 100(2):525-31. PubMed ID: 3093090 [TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of class II MHC antigens in placentae from patients with pemphigoid gestationis: analysis of class II MHC subregion product expression. Borthwick GM; Holmes RC; Stirrat GM Placenta; 1988; 9(1):81-94. PubMed ID: 3283723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]